O'Shaughnessy Asset Management’s Diversified Healthcare Trust DHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$149K Buy
+16,063
New +$132K ﹤0.01% 2092
2022
Q1
– Sell
-25,869
Closed -$80K – 1295
2021
Q4
$80K Sell
25,869
-50,820
-66% -$164K ﹤0.01% 1137
2021
Q3
$260K Sell
76,689
-2,695
-3% -$10.2K 0.01% 915
2021
Q2
$332K Sell
79,384
-19,954
-20% -$82.4K 0.01% 817
2021
Q1
$475K Buy
99,338
+43,588
+78% +$201K 0.01% 627
2020
Q4
$230K Buy
55,750
+36,213
+185% +$143K 0.01% 779
2020
Q3
$69K Buy
+19,537
New +$76.2K ﹤0.01% 1007
2019
Q1
– Sell
-40
Closed – – 934
2018
Q4
$0 Buy
+40
New +$594 ﹤0.01% 941

Other funds holding DHC

O'Shaughnessy Asset Management's DHC Position: Q2 2026 in Review

O'Shaughnessy Asset Management opened a new position in Diversified Healthcare Trust (DHC) in Q2 2026: 16,063 shares worth $149K. The stake represents ﹤0.01% of the portfolio and ranks #2092 among its holdings. This is a return to the name: O'Shaughnessy Asset Management previously reported a position in DHC as recently as Q4 2021.

O'Shaughnessy Asset Management first reported a position in DHC in Q4 2018 and has held it in 8 quarters since. The position peaked at $475K in Q1 2021. 239 funds tracked by Wall St. Rank hold DHC as of Q2 2026.

  • O'Shaughnessy Asset Management held 16,063 shares of Diversified Healthcare Trust worth $149K as of Q2 2026.
  • Diversified Healthcare Trust was a new O'Shaughnessy Asset Management position in Q2 2026.
  • Diversified Healthcare Trust made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #2092 holding.
  • O'Shaughnessy Asset Management first reported a position in Diversified Healthcare Trust in Q4 2018 and has held it in 8 quarters since.
  • O'Shaughnessy Asset Management's Diversified Healthcare Trust position peaked at $475K in Q1 2021.
  • 239 funds tracked by Wall St. Rank held Diversified Healthcare Trust as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.